Method of evaluating neutrophil activity
AssigneeHamamatsu Photonics K.K.
InventorsKimiko KAZUMURA, Kozo TAKEUCHI
Life of this patent
Estimating the term…
Abstract
The present invention relates to a method of evaluating neutrophil activity, which includes: evaluating neutrophil activity based on an index derived from measurement results of myeloperoxidase (MPO) activity or superoxide production of a biological sample to which a neutrophil stimulant is added, in which the index is a time from addition of the neutrophil stimulant to rise of a peak of the MPO activity or the superoxide production.
Claims10
A method of evaluating neutrophil activity, comprising:
- evaluating neutrophil activity based on an index derived from measurement results of myeloperoxidase (MPO) activity or superoxide production of a biological sample to which a neutrophil stimulant is added,
- wherein the index is a time from addition of the neutrophil stimulant to rise of a peak of the MPO activity or the superoxide production.
A method of collecting data for determining whether or not a subject is suffering from a disease associated with oxidative stress due to excessively activated neutrophils, or whether or not the subject is in a condition associated with oxidative stress due to excessively activated neutrophils, the method comprising:
- deriving the data from measurement results of MPO activity or superoxide production of a biological sample to which a neutrophil stimulant is added,
- wherein the data is a time from addition of the neutrophil stimulant to rise of a peak of the MPO activity or the superoxide production, and
- the biological sample is a biological sample collected from the subject.
A method of collecting data for determining effect of treatment on a disease or a condition associated with oxidative stress due to excessively activated neutrophils, in a subject, the method comprising:
- deriving the data from measurement results of MPO activity or superoxide production of a biological sample to which a neutrophil stimulant is added,
- wherein the data is a time from addition of the neutrophil stimulant to rise of a peak of the MPO activity or the superoxide production, and
- the biological sample is a biological sample collected from the subject after the treatment.
Dependencies are inferred from the claim text.